Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study
Urologic Oncology: Seminars and Original Investigations, 06/04/2012
Banek S et al. – Fluorescence–in–situ–hybridization showed a performance in detecting bladder cancer comparable to cytology but a larger number or false–positive results. It remains to be investigated if chromosomal instability can be detected earlier than morphologic changes of exfoliated bladder cancer cells.